Production (Stage)
Bruker Corporation
BRKR
$35.50
-$0.84-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 801.40M | 979.60M | 864.40M | 800.70M | 721.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 801.40M | 979.60M | 864.40M | 800.70M | 721.70M |
| Cost of Revenue | 405.30M | 481.00M | 437.60M | 402.50M | 362.20M |
| Gross Profit | 396.10M | 498.60M | 426.80M | 398.20M | 359.50M |
| SG&A Expenses | 226.00M | 244.10M | 230.20M | 222.70M | 195.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.90M | -13.70M | 12.10M | 2.60M | 2.80M |
| Total Operating Expenses | 732.30M | 815.80M | 778.00M | 720.00M | 642.60M |
| Operating Income | 69.10M | 163.80M | 86.40M | 80.70M | 79.10M |
| Income Before Tax | 25.50M | 54.60M | 55.10M | 23.70M | 71.80M |
| Income Tax Expenses | 8.70M | 40.70M | 14.80M | 16.10M | 19.80M |
| Earnings from Continuing Operations | 16.80M | 13.90M | 40.30M | 7.60M | 52.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 600.00K | -200.00K | 600.00K | -- | -1.10M |
| Net Income | 17.40M | 13.70M | 40.90M | 7.60M | 50.90M |
| EBIT | 69.10M | 163.80M | 86.40M | 80.70M | 79.10M |
| EBITDA | 119.50M | 216.70M | 137.40M | 125.90M | 113.80M |
| EPS Basic | 0.11 | 0.09 | 0.27 | 0.05 | 0.35 |
| Normalized Basic EPS | 0.27 | 0.63 | 0.32 | 0.32 | 0.36 |
| EPS Diluted | 0.11 | 0.09 | 0.27 | 0.05 | 0.35 |
| Normalized Diluted EPS | 0.27 | 0.63 | 0.32 | 0.32 | 0.36 |
| Average Basic Shares Outstanding | 151.60M | 151.60M | 151.50M | 147.40M | 145.20M |
| Average Diluted Shares Outstanding | 151.90M | 152.00M | 152.00M | 148.00M | 145.90M |
| Dividend Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Payout Ratio | 44.25% | 55.47% | 18.58% | 101.32% | 14.34% |